Oncology

Prostate Cancer Awareness blue ribbon on blue background

Current and future standard of care in prostate cancer

Despite recent advancements in the field of prostate cancer treatment, there remain distinct gaps in the current standard of care needing improvement.

News

Imfinzi becomes first NHS drug for aggressive lung cancer

AstraZeneca's PD-L1 inhibitor Imfinzi is the first drug therapy to be recommended for routine NHS use in limited-stage small cell lung cancer.

Oncology

12 Questions with Rick Coope

Rick Coope is General Manager at Menarini Stemline UK, Ireland, and the Nordics.

Digital

AI medicines are coming: Building the foundations for discov...

News

J&J claims FDA okay for bladder cancer drug TAR-200

Johnson & Johnson has brought its bladder cancer drug TAR-200 to the US market, a year after its prospects were dented by a negative phase 3 readout.

News

Lilly eyes earlier use of blood cancer drug Jaypirca

Lilly's fast-growing blood cancer drug Jaypirca could gain more momentum thanks to a trial suggesting it could move into the first-line setting.

Current and future standard of care in prostate cancer

Imfinzi becomes first NHS drug for aggressive lung cancer

12 Questions with Rick Coope

AI medicines are coming: Building the foundations for discov...

J&J claims FDA okay for bladder cancer drug TAR-200

Lilly eyes earlier use of blood cancer drug Jaypirca

Immunovant's thyroid eye disease drug flunks pivotal trials

Using AI-driven synthetic personas to take your insights fur...

Oncology

Editor's Picks